Volume 23 Issue 6
Jun.  2025
Turn off MathJax
Article Contents
FU Huayu, SU Jiasun, HUANG Jing, XU Juanjuan, LI Meng, HUANG Jinai, DU Juan, LI Jiao. The necessity study of prenatal diagnosis in fetal nuchal translucency from 2.5 to 2.9 mm[J]. Chinese Journal of General Practice, 2025, 23(6): 972-976. doi: 10.16766/j.cnki.issn.1674-4152.004045
Citation: FU Huayu, SU Jiasun, HUANG Jing, XU Juanjuan, LI Meng, HUANG Jinai, DU Juan, LI Jiao. The necessity study of prenatal diagnosis in fetal nuchal translucency from 2.5 to 2.9 mm[J]. Chinese Journal of General Practice, 2025, 23(6): 972-976. doi: 10.16766/j.cnki.issn.1674-4152.004045

The necessity study of prenatal diagnosis in fetal nuchal translucency from 2.5 to 2.9 mm

doi: 10.16766/j.cnki.issn.1674-4152.004045
Funds:

 Z20200026

 Z-A20230308

  • Received Date: 2024-08-11
    Available Online: 2025-09-04
  •   Objective  To estimate the risk of chromosomal abnormalities in cases of fetal nuchal translucency (NT) and explore the necessity of NT from 2.5 to 2.9 mm as an indication for prenatal diagnosis.  Methods  A retrospective analysis was conducted on chromosome-tested results of 2 779 fetuses diagnosed with NT≥ 2.5 mm from January 2016 to June 2021 at the Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region. And follow up on the pregnancy outcome of fetuses with NT values ranging from 2.5 to 2.9 mm. The fetuses were divided into four groups according to different NT values: A (2.5-2.9 mm) 555 cases, B (3.0-3.4 mm) 1 026 cases, C (3.5-3.9 mm) 440 cases, and D (≥4.0 mm) 758 cases.  Results  Among 2 779 cases, 606 of aneuploidy and 2 of triploid were detected; 173 of copy number variation(CNV) were detected. The aneuploidy in groups A, B, C, and D were 45 cases (8.11%), 137 cases (13.35%), 87 cases (19.77%), and 337 cases (44.46%), respectively; The risk of aneuploidy increased with the increase of NT value. And the CNV were 23 cases (4.14%), 61 cases (5.95%), 31 cases (7.05%) and 58 cases (7.65%), respectively. In Group A, the aneuploidy in the cases of increased NT isolated, increased NT with soft marks, and increased NT with structural abnormalities were 22 cases (4.55%), 14 cases (28.57%), and 9 cases (40.91%), respectively. The difference was statistically significant (χ2=67.553, P < 0.001). And the CNV were 20 cases (4.13%), 2 cases (4.08%), and 1 cases (4.55%), respectively. The differences weren ' t statistically significant.  Conclusion  When the NT value is between 2.5-2.9 mm, the risk of chromosomal abnormalities in the fetus is still high. Prenatal diagnosis should be recommended, testing the fetal chromosome karyotype and CNV, in order to reduce the birth defects.

     

  • loading
  • [1]
    赵欣荣, 王彦林, 范阳阳, 等. 胎儿颈项透明层增厚的临床咨询及预后分析[J]. 上海交通大学学报(医学版), 2018, 38(5): 529-532.

    ZHAO X R, WANG Y L, FAN Y Y, et al. Clinical consultation and prognosis analysis of fetus with increased nuchal translucency[J]. J Shanghai Jiaotong University(medical science), 2018, 38(5): 529-532.
    [2]
    倪梦瑶, 李洁, 朱湘玉, 等. 染色体微阵列分析在颈项透明层增厚胎儿产前诊断中的应用[J]. 中华医学遗传学杂志, 2019, 36(10): 970-974.

    NI M Y, LI J, ZHU X Y, et al. Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency[J]. Chin J Med Genet, 2019, 36(10): 970-974.
    [3]
    American College of Obstetricians and Gynecologists (ACOG). Screening for fetal chromosomal abnormalities. ACOG practice bullet in No. 226[J]. Obstet and Gynecol, 2020, 136(4): e48-e69.
    [4]
    ARMOUR C M, DOUDAN S D, BROCK J A, et al. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada[J]. J Med Genet, 2018, 55(4): 215-221.
    [5]
    LEUNG T Y, AU YEUNG K C, LEUNG W C, et al. Prenatal diagnosis of pathogenic genomic imbalance in fetuses with increased nuchal translucency but normal karyotyping using chromosomal microarray[J]. Hong Kong Med J, 2019, 25(4): 30-32.
    [6]
    BOUTOTA M, YARDIN C, MARTIN R, et al. Follow-up of increased nuchal translucency: results of a study of 398 cases[J]. J Gynecol Obstet Hum Reprod, 2022, 51(10): 102482. DOI: 10.1016/j.jogoh.2022.102482.
    [7]
    BUNNELL M E, ADAMS S, PELLETIER A, et al. Increased use of diagnostic testing after increased nuchal translucency: the influence of non-invasive prenatal testing and chromosomal microarray[J]. Prenat Diagn, 2022, 42(13): 1606-1611.
    [8]
    黄婷婷, 周萍, 黎俏, 等. 颈项透明层增厚在产前诊断中的应用[J]. 实用医学杂志, 2020, 36(15): 2152-2156.

    HUANG T T, ZHOU P, LI Q, et al. Application research of fetus with increased nuchal translucency in prenatal diagnosis[J]. Journal of Practical Medicine, 2020, 36(15): 2152-2156.
    [9]
    SU L J, HUANG H L, AN G, et al. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype[J]. Mol Genet Genomic Med, 2019, 7(8): e811. DOI: 10.1002/mgg3.811.
    [10]
    李萌, 蒙达华, 付华钰, 等. 199例妊娠中晚期胎儿室间隔缺损的遗传学因素研究[J]. 中华全科医学, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861

    LI M, MENG D H, FU H Y, et al. Genetic factors of ventricular septal defect in 199 cases in the second or third trimester of pregnancy[J]. Chin J General Practice, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861
    [11]
    SUN Y Y, LIU L, ZHI Y X, et al. Genetic examination for fetuses with increased nuchal translucency by exome sequencing[J]. J Obstet Gynaecol Res, 2023, 49(2): 530-538.
    [12]
    卢虞夫, 赵靖, 雷榆, 等. 无创DNA产前检测对胎儿染色体非整倍体疾病筛查的临床意义[J]. 贵州医科大学学报, 2022, 47(5): 598-603.

    LU Y F, ZHAO J, LEI Y, et al. Clinical significance of non-invasive DNA prenatal detection for fetal chromosomal aneuploidy disease screening[J]. Journal of Guizhou Medical University, 2022, 47(5): 598-603.
    [13]
    NARAVA S, SINGH S B, BARPANDA S, et al. Outcome of pregnancies with first-trimester increased nuchal translucency and cystic hygroma in a tertiary maternity hospital in United Arab Emirates[J]. Int J Gynaecol Obstet, 2022, 159(3): 841-849.
    [14]
    TEKESIN I. Pregnancy outcome in foetuses with increased nuchal translucency-10-years'experience in a prenatal medical practice[J]. J Obstet Gynaecol, 2020, 40(4): 455-460.
    [15]
    SOFIA-GONÇALVES A, GUEDES-MARTINS L. Nuchal translucency and congenital heart defects[J]. Curr Cardiol Rev, 2024, 20(2): 1-13.
    [16]
    HURYN L A, FLAHERTY T, NOLEN R, et al. Novel ophthalmic findings and deep phenotyping in Williams-Beuren syndrome[J]. Br J Ophthalmol, 2023, 107(10): 1554-1559.
    [17]
    ALQAHTANI A S, PUTOUX A, BONNET DUPEYRON M N, et al. Postnatal clinical phenotype of five patients with Pallister-Killian syndrome (tetrasomy 12p): interest of array CGH for diagnosis and review of the literature[J]. Mol Genet Genomic Med, 2019, 7(10): e00939. DOI: 10.1002/mgg3.939.
    [18]
    中华医学会医学遗传学分会遗传病临床实践指南撰写组. Rett综合征的临床实践指南[J]. 中华医学遗传学, 2020, 37(3): 308-312.

    Writing Group for Practice Guidelines for Diagnosis and Treatment of Genetic Diseases, Medical Genetics Branch of Chinese Medical Association. Clinical practice guidelines for Rett syndrome[J]. Chin J Med Genet, 2020, 37(3): 308-312.
    [19]
    SU J S, QIN Z L, FU H Y, et al. The correlations of prenatal renal ultrasound abnormalities with pathogenic CNVs in a large Chinese cohort[J]. Ultrasound Obstet Gynecol, 2022, 59(2): 226-233.
    [20]
    BETA J, ZHANG W, GERIS S, et al. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis[J]. Ultrasound Obstet Gynecol, 2019, 54(4): 452-457.
    [21]
    于艳, 杨彦. 羊水穿刺与无创DNA产前检测的对照研究[J]. 现代医药卫生, 2021, 37(5): 803-806.

    YU Y, YANG Y. Comparative study of amniocentesis and non-invasive prenatal testing[J]. J Mod Med Health, 2021, 37(5): 803-806.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (66) PDF downloads(2) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return